Dexcom, Inc. 8-K Report: Key Insights from October 24, 2025 Filing

Based on the provided XML snippet from the financial report, here are the key insights and information extracted:

1. Entity Information:

• Company Name: Dexcom, Inc.
• State of Incorporation: Delaware (DE)
• SEC Central Index Key (CIK): 0001093557
• IRS Employer Identification Number (EIN): 33-0857544
• Address: 6340 Sequence Drive, San Diego, CA 92121
• Phone Number: 858-200-0200

2. Filing Information:

• Filing Type: 8-K (Current Report)
• Date of Filing: October 24, 2025
• Filing Identifier: 000-51222
• Common Stock: The company's shares have a par value of $0.001 per share.

3. Market Information:

• Ticker Symbol: DXCM
• Exchange: NASDAQ

4. Period Covered:

• The reporting period for this filing is a single day: October 24, 2025.

5. XBRL Information:

• The document is structured in XBRL format, which is commonly used for reporting financial data to the SEC, allowing for easier data extraction and analysis.

Insights:

• Dexcom, Inc. appears to be proactive in its reporting, evidenced by the filing of an 8-K, which often includes significant corporate events or changes.
• The specific date of the filing indicates that the information is current and relevant as of that date, potentially offering insights into recent developments within the company.
• The use of XBRL format suggests that the company is complying with regulatory requirements for transparency and data sharing.

This summary encapsulates the essential information from the provided section of the financial report, highlighting the company’s identity, recent filing activity, and compliance with SEC regulations.